News tagged with lamotrigine

Perampanel for epilepsy: No proof of added benefit

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In an early benefit assessment according ...

Jan 30, 2013
popularity not rated yet | comments 0

A more ethical way to compare epilepsy treatments

For the first time, a new research methodology recently approved by the Food and Drug Administration has been used to demonstrate that converting patients from one anti-epileptic drug to another - in this case, lamotrigine ...

Dec 05, 2011
popularity not rated yet | comments 0